Search research articles
Contact Us
Filters
Showing results (41-50 of 195) with videos related to
Page
of 20
Sort By:
Leukemia Research
|
August 24, 2016
Cepheid xpert monitor platform for the confirmation of BCR-ABL1 IS conversion factors for the molecular monitoring of chronic myeloid leukaemia
Gareth Gerrard, Hui En Foong, Katherine Mudge, et al.
American Journal of Hematology
|
September 9, 2015
The impact of dasatinib on pregnancy outcomes
Jorge E Cortes, Elisabetta Abruzzese, Ekaterina Chelysheva, et al.
Blood
|
March 16, 2007
The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia
Mohamad Mohty, Agnes S M Yong, Richard M Szydlo, et al.
Blood
|
October 6, 2006
Varying response to escalating the dose of imatinib in patients with CML who "acquire" a BCR-ABL M244V mutant allele
Mona Anand, Jamshid Khorashad, David Marin, et al.
Leukemia & Lymphoma
|
April 12, 2013
Rapid initial response of myeloma hyperammonemic encephalopathy to L-ornithine-L-aspartate and dexamethasone therapy
Amit Patel, Umeer Waheed, Stephen J Brett, et al.
Acta Haematologica
|
October 18, 2005
Anti-angiogenic effect of bortezomib in patients with multiple myeloma
Marianna Politou, Kikkeri Naresh, Evangelos Terpos, et al.
European Journal of Haematology
|
November 1, 2012
Lymphodepletion chemotherapy followed by donor leukocytes for post-transplantation relapse of myelofibrosis after previous donor leukocyte infusion failure
Emma Lucy Neave, Heike Schwarb, Abdurrazag Shlebak, et al.
British Journal of Haematology
|
June 11, 2020
An ex vivo investigation of interactions between primary acute myeloid leukaemia and mesenchymal stromal cells yields novel therapeutic targets
Avirup Chowdhury, Sandra Loaiza, Eva Yebra-Fernandez, et al.
Blood
|
September 8, 2005
Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML
Agnes S M Yong, Richard M Szydlo, John M Goldman, et al.
Blood
|
May 3, 2002
Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation
Eduardo Olavarria, Charles Craddock, Francesco Dazzi, et al.
Page
of 20
Search research articles
Search
Showing results (41-50 of 195) with videos related to
Sort By:
Page
of 20
Leukemia Research
|
August 24, 2016
Cepheid xpert monitor platform for the confirmation of BCR-ABL1 IS conversion factors for the molecular monitoring of chronic myeloid leukaemia
Gareth Gerrard, Hui En Foong, Katherine Mudge, et al.
American Journal of Hematology
|
September 9, 2015
The impact of dasatinib on pregnancy outcomes
Jorge E Cortes, Elisabetta Abruzzese, Ekaterina Chelysheva, et al.
Blood
|
March 16, 2007
The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia
Mohamad Mohty, Agnes S M Yong, Richard M Szydlo, et al.
Blood
|
October 6, 2006
Varying response to escalating the dose of imatinib in patients with CML who "acquire" a BCR-ABL M244V mutant allele
Mona Anand, Jamshid Khorashad, David Marin, et al.
Leukemia & Lymphoma
|
April 12, 2013
Rapid initial response of myeloma hyperammonemic encephalopathy to L-ornithine-L-aspartate and dexamethasone therapy
Amit Patel, Umeer Waheed, Stephen J Brett, et al.
Acta Haematologica
|
October 18, 2005
Anti-angiogenic effect of bortezomib in patients with multiple myeloma
Marianna Politou, Kikkeri Naresh, Evangelos Terpos, et al.
European Journal of Haematology
|
November 1, 2012
Lymphodepletion chemotherapy followed by donor leukocytes for post-transplantation relapse of myelofibrosis after previous donor leukocyte infusion failure
Emma Lucy Neave, Heike Schwarb, Abdurrazag Shlebak, et al.
British Journal of Haematology
|
June 11, 2020
An ex vivo investigation of interactions between primary acute myeloid leukaemia and mesenchymal stromal cells yields novel therapeutic targets
Avirup Chowdhury, Sandra Loaiza, Eva Yebra-Fernandez, et al.
Blood
|
September 8, 2005
Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML
Agnes S M Yong, Richard M Szydlo, John M Goldman, et al.
Blood
|
May 3, 2002
Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation
Eduardo Olavarria, Charles Craddock, Francesco Dazzi, et al.
Page
of 20